Samsung BioLogics implements N-1 perfusion for commercial application

Contract Manufacturing |  News | 0 Comment | 13 Aug, 2019

Samsung BioLogics (SBL) has successfully performed N-1 (3,000L) perfusion with Alternating Tangential Flow (ATF) device to supply the 15,000L commercial production process in the Plant 3 fa...Read more

AUM Biosciences expands pipeline with new global license agreement

Contract Manufacturing |  News | 0 Comment | 19 Jul, 2019

AUM Biosciences (AUM), an award-winning company focused on the development of innovative and affordable oncology medicines with high unmet medical need in Asia, on 18th July 2019 announced ...Read more

Wize Pharma enters into JV with Cannabics Pharmaceuticals

Contract Manufacturing |  News | 0 Comment | 01 Jul, 2019

Wize Pharma, an Israel based clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, has announced that the Company and Cannabics Pharmaceutical...Read more

Concept Life Sciences Opens New Pharmaceutical Manufacturing Support Services

Contract Manufacturing |  News | 0 Comment | 28 Jun, 2019

Concept Life Sciences, a knowledge-based provider of integrated discovery, development and analytical services, on 18 June 2019, unveiled a new, state-of-the-art clinical and niche commerci...Read more

Cobra Biologics, Symbiosis complete £4.8M viral vector supply chain collaboration

Contract Manufacturing |  News | 0 Comment | 26 Jun, 2019

Cobra Biologics, an international contract development and manufacturing organisation (CDMO) focused on viral vector drug substance production, and Symbiosis Pharmaceutical Services (S...Read more

EMA accepts First "China-Developed" Biosimilar - Henlius HLX02 MAA for Review

Contract Manufacturing |  News | 0 Comment | 24 Jun, 2019

Henlius, a leading biotech company in China developing both biosimilar and innovative biologics, on 21 June 2019, announced that the European Medicines Agency (EMA) has officially...Read more

WuXi Biologics to expand integrated biologics conjugation solution center

Contract Manufacturing |  News | 0 Comment | 21 Jun, 2019

WuXi Biologics ("WuXi Bio"), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, on 21 J...Read more

Univercells granted $14.3M to deliver measles and rubella vaccines in LMICs

Contract Manufacturing |  News | 0 Comment | 17 Jun, 2019

Univercells, on 13 June 2019, announced that it has been awarded a $14.3M grant by the Bill & Melinda Gates Foundation to increase the availability of measles and rubella (M&R)...Read more

CytoDyn, Samsung BioLogics formalize manufacturing partnership

Contract Manufacturing |  News | 0 Comment | 31 May, 2019

CytoDyn Inc., a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications and Samsung BioLogics met at the ...Read more

GeneDesign joins Ajinomoto Bio-pharma

Contract Manufacturing |  News | 0 Comment | 09 Apr, 2019

Ajinomoto Bio-Pharma, a leading provider of biopharmaceutical contract development and manufacturing services has announced that GeneDesign has joined the global organization. GeneDesi...Read more

WuXi Biologics enters into commercial manufacturing partnership with Amicus

Contract Manufacturing |  News | 0 Comment | 13 Feb, 2019

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Amicus Therapeut...Read more

NextPharma to acquire Santen's Tampere manufacturing facility

Contract Manufacturing |  News | 0 Comment | 30 Jan, 2019

Santen SA and NextPharma have announced that Santen’s Tampere manufacturing facility and related operations will be acquired by NextPharma, a leading European pharmaceutical Contract ...Read more

Merck, Roche to renew global distribution agreement

Contract Manufacturing |  News | 0 Comment | 15 Jan, 2019

Merck and Roche have agreed to renew their current distribution agreement for the Biochemical Reagents and Kapa Biosystems product portfolios, as well as select qPCR & Nu...Read more

Fujifilm to invest 10B Yen in Bio CDMO biz

Contract Manufacturing |  News | 0 Comment | 08 Jan, 2019

FUJIFILM Corporation announced plans to invest approximately JPY 10 billion (approximately $90 million U.S. dollars) in order to expand its Bio Contract Development and Manufacturing Organi...Read more

Sistema and VTB to create a major pharmaceuticals holding

Contract Manufacturing |  News | 0 Comment | 31 Dec, 2018

Sistema PJSFC (“Sistema”), a publicly traded diversified Russian holding company, announces it has acquired an equity interest in JSC Pharmaceutical Enterprise Obolenskoe (&ldqu...Read more

Helsinn gives exclusive rights to Menarini for Pracinostat

Contract Manufacturing |  News | 0 Comment | 24 Dec, 2018

Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and Menarini, an Italian biopharmaceutical Group active in 136 countries worldwide, announced that Be...Read more

Chengdu firms ink pacts for 18 collaborative projects with Thai peers

Contract Manufacturing |  News | 0 Comment | 19 Dec, 2018

The highlights of Thailand-Chengdu Cooperation Week 2018, the Economic and Trade Exchange and Business Matching Exchange Meeting, as well as the Chengdu Promotion Meeting and Signing Ceremo...Read more

Cobra, Pall, Cell and Gene Therapy Catapult win £1.5M Innovate UK grant

Contract Manufacturing |  News | 0 Comment | 26 Nov, 2018

Singapore –Cobra Biologics, an international contract development and manufacturing organization (CDMO) with a focus on advanced therapy medicinal products (ATMPs) has ...Read more